RESUMEN
The genus Desmodium includes about 350 species, distributed in tropical and subtropical regions around the world. The objective of this review wa s to associate the traditional medicinal uses of the genus Desmodium with its biological activities reported in the scientific literature. Traditional medicinal uses and biological activities were described in 56 species. More than 100 traditional medicina l uses have been reported in 43 countries, highlighting the use in inflammatory, gastrointestinal and infectious processes, muscular pain, rheumatic, renal and hepatic affections. Among the 45 biological activities experimentally evaluated, antioxidant, an timicrobial, anti - inflammatory, hepatoprotective and antinociceptive were the most reported. The species with the highest number of studies were D. gangeticum, D. adscendens and D. styracifolium. In conclusion, several traditional medicinal uses have been experimentally supported, demonstrating the pharmacological potential of this genus.
El género Desmodium incluye alrededor de 350 especie s, distribuidas en regiones tropicales y subtropicales alrededor del mundo. El objetivo de esta revisión fue asociar los usos medicinales tradicionales del género Desmodium con sus actividades biológicas reportadas en la literatura científica. Los usos med icinales tradicionales y las actividades biológicas fueron descritos en 56 especies. Más de 100 usos medicinales tradicionales han sido reportados en 43 países, destacándose el uso en procesos inflamatorios, gastrointestinales e infecciosos, dolores muscul ares, reumáticos, afecciones renales y hepáticas. Dentro de las 45 actividades biológicas evaluadas experimentalmente, las más reportadas fueron la antioxidante, antimicrobiana, antiinflamatoria, hepatoprotectora y antinociceptiva. Las especies con mayor n úmero de estudios fueron D. gangeticum, D. adscendens y D. styracifolium. En conclusión, varios usos medicinales tradicionales han sido experimentalmente respaldados, demostrando el potencial farmacológico de este género.
Asunto(s)
Plantas Medicinales , Fabaceae , Medicina TradicionalRESUMEN
The rapid spread of COVID-19 on all continents and the mortality induced by SARS-CoV-2 virus, the cause of the pandemic coronavirus disease 2019 (COVID-19) has motivated an unprecedented effort for vaccine development. Inactivated viruses as well as vaccines focused on the partial or total sequence of the Spike protein using different novel platforms such us RNA, DNA, proteins, and non-replicating viral vectors have been developed. The high global need for vaccines, now and in the future, and the emergence of new variants of concern still requires development of accessible vaccines that can be adapted according to the most prevalent variants in the respective regions. Here, we describe the immunogenic properties of a group of theoretically predicted RBD peptides to be used as the first step towards the development of an effective, safe and low-cost epitope-focused vaccine. One of the tested peptides named P5, proved to be safe and immunogenic. Subcutaneous administration of the peptide, formulated with alumina, induced high levels of specific IgG antibodies in mice and hamsters, as well as an increase of IFN-γ expression by CD8+ T cells in C57 and BALB/c mice upon in vitro stimulation with P5. Neutralizing titers of anti-P5 antibodies, however, were disappointingly low, a deficiency that we will attempt to resolve by the inclusion of additional immunogenic epitopes to P5. The safety and immunogenicity data reported in this study support the use of this peptide as a starting point for the design of an epitope restricted vaccine.